why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and now, after a brief tease below, is therefore probably worth buying on that basis alone.

From memory, Shares mag was also quite excited about this stock a week or two back, even though that medium has supported some classic stinkers in its time

Hola! Just sent you a mail, in case you haven't seen.

Soul.

Hola! ... what's that????? ..... "Guten Abend," meinst du

LOL - richtig! Just trying to impress with my linguistic versatility :o)

PS, not sure about SHP as I haven't looked recently, but it seems to be a lot more mobile than juniors such as IOV, VER, PLE, etc.

SHP is a genuine and "proper" company

Anyhoo, got to switch off this PC at last and do some serious telly-watching. Blame Silvermede for shackling me to my computer for too long !!

SHP is a genuine and "proper" company

not a shell? disappointing . . . .

I will attempt to do you the honour of looking into it tomorrow (but am currently a little "researched out" at the mo and may just stick to spending all day watching SOLA and GOL rise and SEO plummet :o))

Tschuss, bis dann!!

sp has been very lively in the last few days ..... there are some thoughts that SHP could be a t/o target, but have also picked up .....



Specialty pharma group Shire should find out today whether US medicine regulator have granted marketing approval for its new drug to treat hyperactivity, and the ruling is likely to have major impact on the company's share price.

Currently referred to as NRP-104, analysts expect the drug be a major profit driver for Shire in the next few years. Sales are seen topping 1 bln usd within two years of its launch, forecast for next year.

The Food and Drug Administration is due to deliver its opinion today. Most observers are anticipating an 'approvable letter', whereby the FDA extends its review to iron out remaining issues.



If very lucky, will not only get that good news, but also a bid approach

hmm! ..... have seen no announcement of any kind, which is slightly strange and perhaps of concern ..... let's see if w/e throws up anything .... at least it will be an FDA-generated announcement, so any utterances will have to be passed on, whether good or bad.

for the record, i noted two large buys of 110k and 550k at the last knocking yesterday .... that's quite hefty money

i feel like the lone ranger, or is it a prophet in my own land? ...... expect some very lively action on this share, and arguably it even increases the company's desirability axs a t/o target.



Specialty pharma group Shire PLC said its collaborative partner New River Pharmaceuticals Inc has received an approvable letter from the US Food and Drug Administration for NRP104 (lisdexamfetamine dimesylate), for the treatment of pediatric Attention-Deficit/Hyperactivity Disorder (ADHD).

A statement from Shire said the result is generally consistent with historical responses from FDA following their review of New Drug Applications for ADHD medications.

According to the FDA's letter, marketing approval of NRP104 is contingent upon final scheduling by the US Drug Enforcement Administration (DEA).

No additional studies have been requested by the FDA as a condition for approval of NRP104, it added.

Shire and New River will continue dialog with FDA officials to agree upon a final trade name. Shire and New River Pharmaceuticals are preparing for a product launch in Q2 2007, pending final labelling and scheduling discussions.

'This approvable letter for NRP104 is positive news for Shire and our partner New River Pharmaceuticals,' said Shire chief executive Matthew Emmens.

Cannot believe this share is of no interest to any of you guys ...... +130 today to about 1000, and while there may some profit taking (hope so!), still plenty of upside, with just the chance that the company will get eaten up by one of the giants

1050p tomorrow is my guess,please dyor,but this momentum might continue just like corus i hope.

originally took profit, but bought back in this morning ...... this has to be a winner, which is more than one can say for so many of the "scallywag" stocks like GOO and CHP and VOG and SEY (we won't mention SEO!), all of which I also hold (not SEO!), on the basis that just perhaps one or two will come up with sweeties.

Perhaps time to revisit this "real" pharma company ...... Rumours have long circulated the market about consolidation in this sector, and SHP would certainly make a tasty morsel with its track record and pipeline ...... all time high was about 15.00 but that was in 2001 (I think), so probably of little relevance, except questionably to point to a possible buy-out level

gob and wallet have now joined up!

Cynic you are so funny sometimes, hows your pain threshold? still a good trade in my opinion.
good luck
regards

position is in the money, so at the mo, am a happy bunny (boiler) ...... to answer the question to which i think you allude ..... some stocks i hold a relatively long time; others i trade within a few weeks or even days

not only, as "stolen" from the Indie ...... Shire is expected to get the green light in a matter of days from US regulators to launch Mesavance, its biggest new drug in years ....... but the company is also a likely candidate for t/o at some time, perhaps sooner rather than later

sp rather gone to sleep ..... 200 dma left miles behind ... sp currently "teasing" just below 25 dma ..... rsi shows neutra/oversold ...... trend still steadily upwards



red = 25 dma
green = 50 dma

yet another quality stock that you guys seem to ignore ...... confess to feeling a bit like the prophet in his own land (only Cassandra alter ego when suggesting gloom and doom!) ..... top notch results just abnnounced ..... sp just heading north through 25 dma (potential resistance) ...... rsi neutral to o'sold .... company still a potential t/o target

will be interesting to see what the press and analysts make of these results, but i would hope (reasonably expect) that they are also very positive .... would be nice to see sp holding above that psychological 1100 level